Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2651
BBVA Argentina
BBAR
$2.58B
| $809K | ﹤0.01% |
215,800
-85,691
| -28% | -$280K |
2019 Q3
3 quarters
|
|
2652
Uniti Group
UNIT
$1.67B
| $809K | ﹤0.01% |
+86,486
| New | +$649K |
2020 Q2
0 quarters
|
|
|
SECO
2653
DELISTED
Secoo Holding Limited ADR
SECO
| $808K | ﹤0.01% |
25,020
+14,670
| +142% | +$421K |
2019 Q1
5 quarters
|
|
2654
Amplify Cybersecurity ETF
HACK
$3.6B
| $805K | ﹤0.01% |
+18,100
| New | +$751K |
2020 Q2
0 quarters
|
|
2655
Lifecore Biomedical
LFCR
$244M
| $805K | ﹤0.01% |
101,100
+82,800
| +452% | +$854K |
2020 Q1
1 quarter
|
|
2656
Turkcell
TKC
$4.37B
| $801K | ﹤0.01% |
+139,019
| New | +$709K |
2020 Q2
0 quarters
|
|
|
WINS
2657
DELISTED
Wins Finance Holdings Inc. Ordinary Shares (Cayman Islands)
WINS
| $800K | ﹤0.01% |
20,200
+2,300
| +13% | +$35.9K |
2019 Q3
3 quarters
|
|
2658
Bio Green Med Solution Inc
BGMS
$5.62M
| $798K | ﹤0.01% |
48
+30
| +167% | +$559K |
2018 Q1
9 quarters
|
|
|
JE
2659
DELISTED
Just Energy Group Inc
JE
| $798K | ﹤0.01% |
47,031
-22,623
| -32% | -$364K |
2014 Q3
23 quarters
|
|
|
CIZN
2660
DELISTED
Citizens Holding Co.
CIZN
| $798K | ﹤0.01% |
31,912
+9,311
| +41% | +$209K |
2016 Q3
15 quarters
|
|
|
CFRX
2661
DELISTED
ContraFect Corporation
CFRX
| $797K | ﹤0.01% |
1,560
+724
| +87% | +$355K |
2017 Q3
11 quarters
|
|
|
EVOL
2662
DELISTED
Evolving Systems, Inc.
EVOL
| $796K | ﹤0.01% |
736,936
+14,221
| +2% | +$13.6K |
2013 Q2
28 quarters
|
|
2663
First Trust Capital Strength ETF
FTCS
$7.54B
| $795K | ﹤0.01% |
13,600
+1,100
| +9% | +$61.5K |
2020 Q1
1 quarter
|
|
|
TREC
2664
DELISTED
Trecora Resources
TREC
| $795K | ﹤0.01% |
126,749
+24,364
| +24% | +$136K |
2014 Q1
25 quarters
|
|
2665
Acushnet Holdings
GOLF
$4.62B
| $793K | ﹤0.01% |
22,800
-71,200
| -76% | -$2.11M |
2019 Q3
3 quarters
|
|
2666
Oramed Pharmaceuticals
ORMP
$180M
| $792K | ﹤0.01% |
224,315
+35,900
| +19% | +$120K |
2017 Q2
12 quarters
|
|
|
EVFM
2667
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $788K | ﹤0.01% |
18,574
+17,627
| +1,861% | +$1.19M |
2019 Q3
3 quarters
|
|
2668
LeMaitre Vascular
LMAT
$1.85B
| $787K | ﹤0.01% |
29,800
-14,000
| -32% | -$366K |
2019 Q2
4 quarters
|
|
|
GDP
2669
DELISTED
Goodrich Petroleum Corporation Common Stock
GDP
| $783K | ﹤0.01% |
108,800
-22,000
| -17% | -$155K |
2017 Q3
11 quarters
|
|
2670
Trio-Tech International Common Stock
TRT
$58.9M
| $782K | ﹤0.01% |
499,960
-10,800
| -2% | -$15.6K |
2013 Q2
28 quarters
|
|
2671
NLI Holdings
NL
$339M
| $781K | ﹤0.01% |
229,114
+5,600
| +3% | +$17.4K |
2014 Q4
22 quarters
|
|
2672
Ryerson Holding Corp
RYZ
$1.36B
| $781K | ﹤0.01% |
138,700
-96,829
| -41% | -$479K |
2019 Q4
2 quarters
|
|
2673
DELISTED
Warner Bros
WBD
| $781K | ﹤0.01% |
37,000
-81,400
| -69% | -$1.76M |
2019 Q4
2 quarters
|
|
|
WSTL
2674
DELISTED
Westell Technologies Inc
WSTL
| $781K | ﹤0.01% |
953,981
+47,211
| +5% | +$37.9K |
2013 Q2
28 quarters
|
|
2675
Star Equity Holdings
STRR
$38.1M
| $780K | ﹤0.01% |
88,596
+5,800
| +7% | +$52.5K |
2013 Q2
28 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.